Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Helicobacter pylori

Helicobacter pylori gastritis—a novel distinct disease entity

Nature Reviews Gastroenterology & Hepatology volume 12, pages 556–557 (2015)Cite this article

Subjects

A global consensus report on Helicobacter pylori gastritis has been developed. Topics discussed include whether dyspepsia caused by H. pylori infection is separate from functional dyspepsia or not, the evaluation method for H. pylori-induced gastritis, eradication therapy for H. pylori gastritis to prevent gastric carcinogenesis and management after H. pylori eradication.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Major findings from the Kyoto Global Consensus Meeting on Helicobacter pylori gastritis.

References

  1. Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y. & El-Omar, E. M. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64, 1353–1367 (2015).

    Article  Google Scholar 

  2. Tack. et al. Functional gastroduodenal disorders. In ROME III: the Functional Gastrointestinal Disorders (ed. Drossman, D. A.). 419–486 (Degnon Associates, 2006).

    Google Scholar 

  3. Tack, J. et al. Functional gastroduodenal disorders. Gastroenterology 130, 1466–1479 (2006).

    Article  Google Scholar 

  4. Suzuki, H., Nishizawa, T. & Hibi, T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia? J. Gastroenterol. Hepatol. 26 (Suppl. 3), 42–45 (2011).

    Article  Google Scholar 

  5. Suzuki, H. & Moayyedi, P. Helicobacter pylori infection in functional dyspepsia. Nat. Rev. Gastroenterol. Hepatol. 10, 168–174 (2013).

    Article  Google Scholar 

  6. Zhao B. et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J. Clin. Gastroenterol. 48, 241–247 (2014).

    Article  CAS  Google Scholar 

  7. Saito, Y. et al. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology 140, 189–198 (2011).

    Article  CAS  Google Scholar 

  8. Saka, A., Yagi, K. & Nimura, S. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy. Dig. Endosc. http://dx.doi.org/10.1111/den.12483.

  9. Dixon, M. F., Genta, R. M., Yardley, J. H. & Correa, P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20, 1161–1181 (1996).

    Article  CAS  Google Scholar 

  10. Sugano, K. Should we still subcategorize Helicobacter pylori-associated dyspepsia as functional disease? J. Neurogastroenterol. Motil. 17, 366–371 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan

    Hidekazu Suzuki & Hideki Mori

Authors
  1. Hidekazu Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideki Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hidekazu Suzuki.

Ethics declarations

Competing interests

During the past 2 years, H.S. has received scholarship funds for research from Astellas, Astra-Zeneca, Otsuka Pharmaceutical, Takeda Pharmaceutical and Zeria Pharmaceutical. and received service honouraria from Astellas, Astra-Zeneca, Otsuka Pharmaceutical, Takeda Pharmaceutical and Zeria Pharmaceutical. H.S. attended the Kyoto global consensus meeting as one of collaborators, but was not directly involved in writing the report. H.M. declares no competing interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suzuki, H., Mori, H. Helicobacter pylori gastritis—a novel distinct disease entity. Nat Rev Gastroenterol Hepatol 12, 556–557 (2015). https://doi.org/10.1038/nrgastro.2015.158

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2015.158

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing